Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited has received a fine of Rs.10,000 (plus 18% GST) from National Stock Exchange of India Limited for non-compliance with Regulation 44 of SEBI (LODR) Regulations 2015. The company has clarified that the non-compliance was due to an inadvertent oversight and not intentional or deliberate. The fine is related to the submission of XBRL data.

Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 24, 2025, and informed the Exchange regarding voting results.

Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited held its 14th Annual General Meeting on September 29, 2026, where the company's audited financial statements for the year ended March 31, 2026, were adopted, and the reappointment of directors was approved.

Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed from 1st October, 2026, and will remain closed till next 2 working days of the exchange after the declaration of results for the period ended on 30th September, 2026.

Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited has informed the Exchange regarding Cessation of Mrs Raina Singh as Company Secretary & Compliance Officer of the company w.e.f. September 09, 2026.

Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹1,722.53 crore, a 53.4% increase from ₹1,080.41 crore in the same quarter last year. The company's profit before tax for the quarter stood at ₹228.88 crore, with earnings per share (EPS) at ₹1.54.

Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited has issued a corrigendum to correct a typographical error in their previous letter regarding the trading window closure date, which was incorrectly stated as 01/04/2026 and should be 01/07/2026.

Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.